Cover Image

Editorial: Liver diseases and programmed cell death

Saved in:

Bibliographic Details
Main Authors:	Peng Cao (Author), Yongyi Liang (Author), Yi Wang (Author), Chao Mao (Author), Weijia Wang (Author), Sha Li (Author), Lianxiang Luo (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Editorial: Ferroptosis as a novel therapeutic target for inflammation-related diseases
by: Yongyi Liang, et al.
Published: (2023)

Programmed Cell Death in Liver Fibrosis
by: Gao R, et al.
Published: (2023)

The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis
by: Hong-wei Wu, et al.
Published: (2023)

Targeting ferroptosis, a novel programmed cell death, for the potential of alcohol-related liver disease therapy
by: Jing-Fen Shi, et al.
Published: (2023)

Programmed cell death protein-1 (PD-1) protects liver damage by suppressing IFN-γ expression in T cells in infants and neonatal mice
by: Xuangjie Guo, et al.
Published: (2021)

The biology of YAP in programmed cell death
by: Yifan Cheng, et al.
Published: (2022)

Development of novel ALOX15 inhibitors combining dual machine learning filtering and fragment substitution optimisation approaches, molecular docking and dynamic simulation methods
by: Yinglin Liao, et al.
Published: (2024)

Identification of Novel Arachidonic Acid 15-Lipoxygenase Inhibitors Based on the Bayesian Classifier Model and Computer-Aided High-Throughput Virtual Screening
by: Yinglin Liao, et al.
Published: (2022)

A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms
by: Fei Xiong, et al.
Published: (2024)

Programmed Cell Death Protein 1/Programmed Cell Death Protein Ligand 1 Immunosuppressants in Advanced Non-Small Cell Lung Cancer Research Progress in Treatment
by: Feng Li, et al.
Published: (2022)

Molecular mechanisms of programmed cell death in methamphetamine-induced neuronal damage
by: Dongming Guo, et al.
Published: (2022)

Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death
by: Danmei Zhang, et al.
Published: (2023)

Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin
by: Chun-Qing Li, et al.
Published: (2022)

Programmed Cell Death in Asthma: Apoptosis, Autophagy, Pyroptosis, Ferroptosis, and Necroptosis
by: Liu L, et al.
Published: (2023)

Non-Apoptotic Programmed Cell Death in Thyroid Diseases
by: Feihong Ji, et al.
Published: (2022)

Programmed Cell Death
Published: (2020)

Correction: Inhibition of GSK3β activity alleviates acute liver failure via suppressing multiple programmed cell death
by: Danmei Zhang, et al.
Published: (2024)

Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease
by: Xue-Kai Wang, et al.
Published: (2021)

The correlation analysis between the appearance anxiety and personality traits of the medical staff on nasal and facial pressure ulcers during the novel coronavirus disease 2019 outbreak
by: Xiaodi Kong, et al.
Published: (2021)

Excess Deaths of Gastrointestinal, Liver, and Pancreatic Diseases During the COVID-19 Pandemic in the United States
by: Lefei Han, et al.
Published: (2023)

Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review
by: Qin Qiu, et al.
Published: (2020)

Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug
by: Yuchen Wang, et al.
Published: (2021)

Hormesis, Cell Death, and Regenerative Medicine for Neurodegenerative Diseases
by: Guanghu Wang
Published: (2013)

Targeting autophagy: polydatin's role in inducing cell death in AML
by: Ping Fu, et al.
Published: (2024)

Role of the Microenvironment in Mesenchymal Stem Cell-Based Strategies for Treating Human Liver Diseases
by: Shan-jing Xu, et al.
Published: (2021)

Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation
by: Dandan Liu, et al.
Published: (2024)

Cell Death and Disease
Published: (2023)

Editorial: Different cell death modes in cancer treatment
by: Zhaoshi Bai, et al.
Published: (2023)

Ferroptosis as an emerging therapeutic target in liver diseases
by: Yuzhen Lu, et al.
Published: (2023)

Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases
by: Ao Wang, et al.
Published: (2024)

Editorial: Autophagy and Related Transcription Factors in Liver and Gut Diseases
by: Nabil Eid, et al.
Published: (2020)

Zooming in and Out of Programmed Cell Death in Osteoarthritis: A Scientometric and Visualized Analysis
by: Cao S, et al.
Published: (2024)

Positive clinical outcomes following therapy with programmed cell death protein 1/programmed cell death ligand 1 inhibitors in neuroendocrine carcinoma of the cervix
by: Rongyu Liu, et al.
Published: (2022)

Stem Cells and Liver Diseases
by: Zongyi Hu, et al.
Published: (2019)

Oxyresveratrol protects human lens epithelial cells against hydrogen peroxide-induced oxidative stress and apoptosis by activation of Akt/HO-1 pathway
by: Xin Hu, et al.
Published: (2019)

Editorial: Alcohol Consumption and Liver Diseases: From Pathology to Phytotherapy
by: Songtao Li, et al.
Published: (2022)

Editorial: Big data for biomedical research of inflammatory diseases
by: Jingxin Mao, et al.
Published: (2023)

Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches
by: Kexin Cai, et al.
Published: (2024)

Cell life-or-death events in osteoporosis: All roads lead to mitochondrial dynamics
by: Zhichao Li, et al.
Published: (2024)

Shikonin Induced Program Cell Death through Generation of Reactive Oxygen Species in Renal Cancer Cells
by: Ming-Feng Tsai, et al.
Published: (2021)